# Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging

> **NCT01257932** · — · WITHDRAWN · sponsor: **University of California, Irvine**

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Diffuse Optical Spectroscopy Imaging

## Key facts

- **NCT ID:** NCT01257932
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-12
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** According to the NIH definition of clinical trial studies, this study does not meet requirement to be a clinical trial study.
- **Last updated:** 2022-11-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01257932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01257932, "Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01257932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*